Prime Medicine, Inc.
PRME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$195,882 | -$198,133 | -$121,821 | -$165,367 |
| Dep. & Amort. | $6,128 | $4,653 | $2,224 | $568 |
| Deferred Tax | $0 | -$279 | -$964 | -$624 |
| Stock-Based Comp. | $26,068 | $13,910 | $6,459 | $1,746 |
| Change in WC | $31,076 | $2,647 | -$35,401 | $31,176 |
| Other Non-Cash | $9,745 | $11,790 | $17,676 | $98,419 |
| Operating Cash Flow | -$122,865 | -$165,412 | -$131,827 | -$34,082 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,294 | -$8,724 | -$16,095 | -$4,150 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$129,449 | -$104,951 | -$123,336 | -$81,980 |
| Inv. Sales/Matur. | $204,200 | $132,556 | $93,000 | $13,000 |
| Other Inv. Act. | $1,000 | -$170 | -$665 | -$496 |
| Investing Cash Flow | $68,457 | $18,711 | -$47,096 | -$73,626 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $170,136 | $655 | $185,317 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25,740 | $0 | -$3,823 | $269,278 |
| Financing Cash Flow | $195,876 | $655 | $181,494 | $269,278 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $141,468 | -$146,046 | $2,571 | $161,570 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55,070 | $201,116 | $198,545 | $36,975 |
| End Cash | $196,538 | $55,070 | $201,116 | $198,545 |
| Free Cash Flow | -$130,159 | -$174,136 | -$147,922 | -$38,232 |